Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
-
Randomized Controlled Trial
Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
To investigate the efficacy of cholecalciferol (vitamin D3) in raising serum 25-hydroxyvitamin D (25[OH)]D) levels and reducing parathyroid hormone (PTH) levels in patients with chronic kidney disease (CKD). ⋯ Weekly cholecalciferol supplementation appears to be an effective treatment to correct vitamin D status in patients with CKD.